MIST

Milestone Pharmaceuticals

• TipRanks·1d ago

  Analysts Offer Insights on Healthcare Companies: Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and Milestone Pharmaceuticals (MIST)

• TipRanks·05/20 07:19

  Milestone Pharmaceuticals’ Earnings Call Signals Early Momentum

• Simply Wall St·05/15 10:37

  Milestone Pharmaceuticals Inc. (NASDAQ:MIST): Is Breakeven Near?

• Dow Jones·05/14 14:34

  Milestone Pharmaceuticals Is Maintained at Overweight by Wells Fargo

• Dow Jones·05/14 14:34

  Milestone Pharmaceuticals Price Target Cut to $7.00/Share From $8.00 by Wells Fargo

• Benzinga·05/14 14:24

  Wells Fargo Maintains Overweight on Milestone Pharmaceuticals, Lowers Price Target to $7

• TipRanks·05/14 11:17

  Milestone Pharmaceuticals (MIST) Gets a Buy from Piper Sandler

• Reuters·05/14 10:37

  MILESTONE PHARMACEUTICALS, INC. <MIST.O>: WELLS FARGO CUTS TARGET PRICE TO $7 FROM $8

• TipRanks·05/14 00:45

  Milestone Pharmaceuticals’ Earnings Call Highlights Early Launch Momentum

• TipRanks·05/13 21:54

  Milestone Pharmaceuticals files $300M mixed securities shelf

• Benzinga·05/13 21:36

  Milestone Pharmaceuticals May Offer Up To $100M Common Shares Via Cantor Fitzgerald Sales Agreement

• Benzinga·05/13 21:34

  Milestone Pharmaceuticals Files Prospectus To Offer Securities Up To $300M

• Reuters·05/13 21:29

  MILESTONE PHARMACEUTICALS INC - MAY OFFER UP TO $100 MLN COMMON SHARES VIA CANTOR FITZGERALD SALES AGREEMENT - SEC FILING

• TipRanks·05/13 21:05

  Buy Rating Reiterated on Milestone as Cardamyst Traction Grows and AFib Program Advances; $8 Price Target Unchanged